# Pioglitazone Therapy Targeting Fatigue in Breast Cancer

> **NCT05013255** · PHASE2 · RECRUITING · sponsor: **West Virginia University** · enrollment: 30 (estimated)

## Conditions studied

- Breast Cancer
- Muscle Fatigue

## Interventions

- **DRUG:** Pioglitazone 15mg
- **DRUG:** Pioglitazone 30 mg

## Key facts

- **NCT ID:** NCT05013255
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-23
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05013255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05013255, "Pioglitazone Therapy Targeting Fatigue in Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05013255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*